Detalhe da pesquisa
1.
Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials.
Ophthalmology
; 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38253291
2.
Bridging and Validation of the Specific Graves Ophthalmopathy Quality of Life Questionnaire With Health State Utility Values.
Endocr Pract
; 30(5): 470-475, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341128
3.
Teprotumumab for the Treatment of Active Thyroid Eye Disease.
N Engl J Med
; 382(4): 341-352, 2020 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971679
4.
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Ophthalmology
; 129(4): 438-449, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34688699
5.
Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.
Endocr Pract
; 28(9): 842-846, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714862
6.
Characteristics of Diabetic and Nondiabetic Patients With Thyroid Eye Disease in the United States: A Claims-Based Analysis.
Endocr Pract
; 28(2): 159-164, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781042
7.
Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients.
Mol Genet Metab
; 127(4): 336-345, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31326288
8.
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2â¯months to 2â¯years of age with urea cycle disorders.
Mol Genet Metab
; 125(3): 251-257, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30217721
9.
Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials.
Thyroid
; 2024 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38824618
10.
Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States.
JAMA Ophthalmol
; 141(2): 159-166, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36580313
11.
Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials.
Lancet Diabetes Endocrinol
; 9(6): 360-372, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33865501
12.
Quality of Life in Patients with Chronic Thyroid Eye Disease in the United States.
Ophthalmol Ther
; 10(4): 975-987, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34478126
13.
Characteristics, Comorbidities, and Potential Consequences of Uncontrolled Gout: An Insurance-Claims Database Study.
Rheumatol Ther
; 8(1): 183-197, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33284422
14.
Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States.
Ophthalmol Ther
; 10(1): 75-87, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33196932
15.
Pharmacokinetics and Exposure-Response Relationship of Teprotumumab, an Insulin-Like Growth Factor-1 Receptor-Blocking Antibody, in Thyroid Eye Disease.
Clin Pharmacokinet
; 60(8): 1029-1040, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768488
16.
Trends in Treatment of Active, Moderate-to-Severe Thyroid Eye Disease in the United States.
J Endocr Soc
; 4(12): bvaa140, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33195953
17.
Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review.
Adv Ther
; 25(9): 842-57, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18777015
18.
A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Adv Ther
; 35(2): 199-209, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29411268
19.
A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
Pediatr Rheumatol Online J
; 16(1): 41, 2018 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29941047
20.
Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study.
Rheumatol Ther
; 4(2): 363-374, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28819927